Rule CG-DIS-026
Disease claims: what rule CG-DIS-026 checks
Rule CG-DIS-026 is one of the checker's disease claims rules. It cites 21 CFR 101.93(g). The reason, source and safer wording are below.
CG-DIS-026 · Blocks approval · Citation checked against stored text
Claims that a product stops or reverses cognitive decline or memory loss are claims to treat or prevent dementia and related disease.
Source: 21 CFR 101.93(g); FDCA 201(g)(1); FTC Act section 5; FTC Health Products Compliance Guidance
Safer wording: Describe the ingredients. A supplement may not claim to prevent or reverse cognitive decline.
21 CFR 101.93(g) · Needs counsel review
Next step
Check your copy against this rule
Run the checker and every flag cites its rule and source.